– ETX301 nominated as a development candidate for post-amputation neuroma pain, with a planned IND submission in 2027 – SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Encoded Therapeutics, Inc.

This article originally appeared on PolitiFact. President Donald Trump has regularly said that drug-price discounts on his watch are greater than 100%, which isn't mathematically possible. Now his ...

FDA alignment achieved on pivotal study design supporting a planned Biologics License Application (BLA) submission 30-patient pivotal study initiated, evaluating seizure reduction and ...

Encoded Therapeutics has linked its Dravet syndrome gene therapy ETX101 to a 78% reduction in seizures, keeping the biotech on track to start a pivotal study next year. The Californian company’s ...

Upgrading from Pydantic 2.11.9 / Core 2.33.2 to Pydantic 2.12.3 / Core 2.41.4 has changed the way database DSNs are built using py.MySQLDsn.build, which I've traced back to a change in the behaviour ...

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. Believe ...

SAN DIEGO — When we talk about rain chances in the forecast, you often hear meteorologists refer to percentages, but does that really mean? CBS 8's chief meteorologist, Karlene Chavis, helps break it ...

History shows that when just 3.5 percent of a population—about 12 million Americans—engage in peaceful protest, their demands become nearly impossible to ignore. This is particularly relevant today, ...

DNA-encoded libraries have numerous advantages over traditional screening methods, including easy identification of compounds and the large quantity of compounds that can be screened simultaneously.

Encoded Therapeutics is shrinking its headcount by 29% as the gene therapy biotech draws resources away from its early-stage R&D toward its Dravet syndrome program. The asset in question, dubbed ...